{ 49件 }
Fujieda Y, Mader S, Jeganathan V, Arinuma Y, Shimizu Y, Kato M, Oku K, Minami A, Shimizu C, Yasuda S, Atsumi T.
Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Int J Rheum Dis. 2018 Oct 24.
PMID: 30358102
Fujieda Y, Amengual O, Atsumi T.
Pathogenic role of antiphospholipid antibodies: an update.
Lupus. 2018 Oct 3 PMID: 30282558
Omori K, Nomoto H, Nakamura A, Takase T, Cho KY, Ono K, Manda N, Kurihara Y,Aoki S, Atsumi T,Miyoshi H
J Diabetes Investig. 2018 Aug 4
Omori K, Nomoto H, Nakamura A, Takase T, Cho KY, Ono K, Manda N, Kurihara Y,Aoki S, Atsumi T,Miyoshi H
J Diabetes Investig. 2018 Jul 2.
The data of change in macrophage gene expression which induced by perilipin 1 overexpression.
Yamamoto K, Miyoshi H, Cho KY, Nakamura A, Greenberg AS, Atsumi T.
Data Brief. 2018 Aug; 19: 179–182.
Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages.
Takahashi K, Nakamura A, Miyoshi H, Nomoto H, Kitao N, Omori K, Yamamoto K, Cho KY, Terauchi Y, Atsumi T.
Sci Rep. 2018 May 1;8(1):6864.
Yanagiya S, Cho KY, Nakamura A, Nomoto H, Kawamoto Y, Kawakubo K, Komatsu Y, Mitsuhashi T, Miyoshi H, Atsumi T.
Intern Med. 2018 Jun 6
Nakamura H, Shimamura S, Yasuda S, Kono M, Kono M,Fujieda Y, Kato M, Oku K, Bohgaki T, Shimizu T, Iwasaki N, Atsumi T.
Ann Rheum Dis. 2018 PMID: 30076153